Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative window study of denosumab in pre-menopausal women with early breast cancer
2011-006224-21Phase 2Completed
- Sponsor
- Institut Jules Bordet
- Start
- Apr 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of denosumab in breast cancer, sponsored by Institut Jules Bordet. Primary endpoint: Change in Ki67 proliferation index. Started Apr 2013; status: completed.
02
Drugs
denosumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2011-006224-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006224-21.